1 / 7

Autoimmune Disease Diagnostics Market [By Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Di

Autoimmune Disease Diagnostics Market [By Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics); By End User (Hospitals, Diagnostics Centers, and Research Laboratories); and by Regions]: Market size & Forecast, 2018 u2013 2026

Marketupdates
Télécharger la présentation

Autoimmune Disease Diagnostics Market [By Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Di

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Autoimmune Disease Diagnostics Market Market Set to Exceed over USD 5,054.12 Million by 2026

  2. Autoimmune Disease Diagnostics Market Size is Estimated to reach USD 5,054.12 Million by 2026 “Autoimmune Disease Diagnostics Market [By Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics); By End User (Hospitals, Diagnostics Centers, and Research Laboratories); and by Regions]: Market size & Forecast, 2018 – 2026” The global autoimmune disease diagnostics market Size is anticipated to reach over USD 5,054.12 Million by 2026, according to a new research published by Polaris Market Research. In general, our body immune system protects the body from foreign particles such as virus and bacteria. Autoimmune diseases arise when the body immune system attacks one or more healthy cells which are operating normally the cause for this may be the irregularities of genes. The malfunctioning of a body immune system is the outcome of the failure to identify organs, tissues, immune cells, and generating autoantibodies targeting these cells. Autoimmune disease diagnostics market is predominantly driven by key factors such as the increasing occurrence of autoimmune disease. for instance, according to The National Institutes of Health (NIH) 2015, approximately 23.5 million Americans were affected by autoimmune disease. Moreover, increase in automation technologies, patient consciousness regarding rising healthcare concerns, increasing government support, increase in healthcare spending, and easy and rapid performing diagnosis test results and prevention of disease are another factors boosting the market growth. However, huge turnaround time for diagnostic test results, high cost associated with the diagnostics tests, and high frequency of false-positive results are some of the major factors hindering the global autoimmune diagnostics market growth. In addition, lack of awareness concerning the various diseases and diagnostic procedures are another factors affecting the market growth adversely. Browse Detailed Research Report On Autoimmune Disease Diagnostics Market: https://www.polarismarketresearch.com/industry-analysis/global-autoimmune-disease- diagnostics-market The global autoimmune disease diagnostics market is segmented on the basis of type, end user, and geography. On the basis of type, the global autoimmune disease diagnostics market is segmented into systemic autoimmune disease diagnostics and localized autoimmune disease diagnostics. The systemic autoimmune disease diagnostics is further categorized into rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus (SLE), and others. On the other side, the localized autoimmune disease diagnostics is further categorized into multiple sclerosis, type 1 diabetes, hashimoto’s thyroiditis, idiopathic thrombocytopenic purpura, and others. In 2017, localized disease diagnostics dominated the overall market. The dominance is majorly attributed to the existence of large process measurements and moderately higher patient awareness level in comparison to - 2 -

  3. Autoimmune Disease Diagnostics Market Size is Estimated to reach USD 5,054.12 Million by 2026 systemic diseases. On the basis of end users, the global autoimmune disease diagnostics market is segmented into Hospitals, Diagnostics Centers, and Research Laboratories. In terms of geography, North America is estimated to dominate the global autoimmune disease diagnostics market. The dominance is majorly attributed to increasing prevalence of some of the common autoimmune diseases such as type1 diabetes and rheumatoid arthritis. The surge in funding by private and government organizations, growing regulatory scenario observed by World Health Organization (WHO), and advancement in technology are some of the other factors driving the growth of the autoimmune disease diagnostics market in North America. Some major key players in global autoimmune disease diagnostics market includes Haemonetics Corporation, Fresenius Kabi (Fenwal), Asahi Kasei Kuraray Medical Co. Ltd., Terumo BCT, Inc., HemaCare Corporation, Therakos, Inc. and B. Braun Melsungen AG among others. Request for sample: https://www.polarismarketresearch.com/industry-analysis/global- autoimmune-disease-diagnostics-market/request-for-sample Table of Contents 1. Overview and Scope 1.1. Research goal & scope 1.2. Research assumptions 1.3. Research Methodology 1.3.1. Primary data sources - 3 -

  4. Autoimmune Disease Diagnostics Market Size is Estimated to reach USD 5,054.12 Million by 2026 1.3.2. Secondary data sources 1.4. Key take-aways 1.5. Stakeholders 2. Executive Summary 2.1. Market Definition 2.2. Market Segmentation 3. Autoimmune Disease Diagnostics Market Insights 3.1. Autoimmune Disease Diagnostics– Industry snapshot 3.2. Autoimmune Disease Diagnostics- Ecosystem analysis 3.3. Autoimmune Disease Diagnostics Market dynamics 3.3.1. Autoimmune Disease Diagnostics– Market Forces 3.3.1.1. Autoimmune Disease Diagnostics Market driver analysis 3.3.1.2. Autoimmune Disease Diagnostics Market restraint/challenges analysis 3.3.1.3. Autoimmune Disease Diagnostics Market opportunity analysis 3.4. Industry analysis - Porter's five force 3.4.1. Bargaining power of supplier 3.4.2. Bargaining power of buyer 3.4.3. Threat of substitute 3.4.4. Threat of new entrant 3.4.5. Degree of competition 3.5. Autoimmune Disease Diagnostics Market PEST analysis, 2017 3.5.1. Autoimmune Disease Diagnostics Industry trends 3.5.2. Competitive Ranking Analysis 4. Autoimmune Disease Diagnostics Market Size and Forecast by Type 4.1. Key findings 4.2. Systemic autoimmune disease diagnostics 4.2.1. Global market estimates and forecasts, 2017 – 2026 4.2.1.1. Rheumatoid arthritis 4.2.1.2. Ankylosing spondylitis 4.2.1.3. Systemic lupus erythematosus (SLE) 4.2.1.4. Others 4.2.2. Localized autoimmune disease diagnostics 4.2.2.1. Global market estimates and forecasts, 2017 – 2026 4.2.2.1.1. Multiple sclerosis 4.2.2.1.2. Type 1 diabetes 4.2.2.1.3. Hashimoto's Thyroiditis 4.2.2.1.4. Idiopathic thrombocytopenic purpura 4.2.2.1.5. Others 5. Autoimmune Disease Diagnostics Market Size and Forecast by End User 5.1. Key findings 5.2. Hospitals 5.2.1. Global market estimates and forecasts, 2017 – 2026 5.3. Diagnostics Centers 5.3.1. Global market estimates and forecasts, 2017 – 2026 5.4. Research Laboratories 5.4.1. Global market estimates and forecasts, 2017 – 2026 6. Autoimmune Disease Diagnostics Market Size and Forecast by Regions 6.1. Key findings 6.2. North America 6.2.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026 6.2.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026 6.2.3. U.S. 6.2.3.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026 6.2.3.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026 6.2.4. Canada - 4 -

  5. Autoimmune Disease Diagnostics Market Size is Estimated to reach USD 5,054.12 Million by 2026 6.2.4.1. 6.2.4.2. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026 Autoimmune Disease Diagnostics Market by End User, 2017 - 2026 6.3. Europe 6.3.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026 6.3.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026 6.3.3. Germany 6.3.3.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026 6.3.3.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026 6.3.4. UK 6.3.4.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026 6.3.4.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026 6.3.5. France 6.3.5.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026 6.3.5.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026 6.3.6. Italy 6.3.6.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026 6.3.6.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026 6.4. Asia Pacific 6.4.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026 6.4.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026 6.4.3. China 6.4.3.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026 6.4.3.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026 6.4.4. India 6.4.4.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026 6.4.4.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026 6.4.5. Japan 6.4.5.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026 6.4.5.2. Autoimmune Disease Diagnostics Market by Application, 2017 - 2026 6.4.5.3. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026 6.4.6. Australia 6.4.6.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026 6.4.6.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026 6.5. Latin America 6.5.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026 6.5.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026 6.5.3. Brazil 6.5.3.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026 6.5.3.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026 6.5.4. Mexico 6.5.4.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026 6.5.4.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026 6.6. Middle East & Africa 6.6.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026 6.6.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026 7. Company Profiles 7.1. Hoffmann-La Roche Ltd 7.1.1. Overview 7.1.2. Financials 7.1.3. Product Benchmarking 7.1.4. Recent Developments 7.2. Siemens Healthineers 7.2.1. Overview 7.2.2. Financials 7.2.3. Product Benchmarking - 5 -

  6. Autoimmune Disease Diagnostics Market Size is Estimated to reach USD 5,054.12 Million by 2026 7.2.4. Recent Developments 7.3. Abbott Laboratories 7.3.1. Overview 7.3.2. Financials 7.3.3. Product Benchmarking 7.3.4. Recent Developments 7.4. Beckman Coulter, Inc. 7.4.1. Overview 7.4.2. Financials 7.4.3. Product Benchmarking 7.4.4. Recent Developments 7.5. SQI Diagnostics 7.5.1. Overview 7.5.2. Financials 7.5.3. Product Benchmarking 7.5.4. Recent Developments 7.6. Quest Diagnostics 7.6.1. Overview 7.6.2. Financials 7.6.3. Product Benchmarking 7.6.4. Recent Developments 7.7. EUROIMMUN AG 7.7.1. Overview 7.7.2. Financials 7.7.3. Product Benchmarking 7.7.4. Recent Developments 7.8. Diagnostics GmbH & Co. KG 7.8.1. Overview 7.8.2. Financials 7.8.3. Product Benchmarking 7.8.4. Recent Developments 7.9. INOVA Diagnostics, Inc. 7.9.1. Overview 7.9.2. Financials 7.9.3. Product Benchmarking 7.9.4. Recent Developments 7.10. Crescendo Bioscience, Inc. 7.10.1. Overview 7.10.2. Financials 7.10.3. Product Benchmarking 7.10.4. Recent Developments 7.11. bioMerieux SA 7.11.1. Overview 7.11.2. Financials 7.11.3. Product Benchmarking 7.11.4. Recent Developments 7.12. Bio-Rad Laboratories, Inc. 7.12.1. Overview 7.12.2. Financials 7.12.3. Product Benchmarking 7.12.4. Recent Developments 7.13. Hemagen Diagnostics, Inc. 7.13.1. Overview 7.13.2. Financials 7.13.3. Product Benchmarking - 6 -

  7. Autoimmune Disease Diagnostics Market Size is Estimated to reach USD 5,054.12 Million by 2026 7.13.4. Recent Developments Access Press Release on Autoimmune Disease Diagnostics Market: https://www.polarismarketresearch.com/press-releases/global-autoimmune-disease- diagnostics-market About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 7 -

More Related